Aperture Biomedical

Aperture Biomedical is a team of physicians and engineers working to improve vascular access for hemodialysis. As part of the Stanford Biodesign fellowship in medtech innovation, they identified a huge unmet clinical need: the two million people on dialysis depend on a sustainable method to access their blood supply. The life expectancy of an incidence dialysis patient is over five years but the current methods of access last less than a year, leading to expensive repairs and complications related to access management. To solve this need, their team designed a novel therapy to extend the patency of access and reduce downstream complications.